Several companies are in focus today, August 8, 2025, as they release their Q1 results and react to broader market trends. Here's a summary of what's making news:
LIC: Life Insurance Corporation (LIC) reported a standalone net profit of ₹10,987 crore, marking a 5% year-on-year increase for the first quarter. The insurer maintained a strong position in First Year Premium Income with a 63.5% market share, according to IRDAI data. LIC continues to lead the group segment, holding a 76.5% market share, and holds 38.8% of the individual category. LIC's net premium income also rose by 5% to ₹1.19 lakh crore.
BSE: India's oldest stock exchange, BSE, reported a substantial rise in Q1 net profit, which more than doubled year-on-year to ₹539 crore. This is up from ₹494 crore in the previous quarter. Revenue for the quarter experienced a 13% sequential increase, reaching ₹958 crore.
SBI: State Bank of India (SBI) is expected to announce its Q1 results today, with analysts anticipating steady performance. An analyst and institutional investor meet is scheduled for today at 5:15 pm following the results declaration. Net interest income is expected to fall over 3% to ₹42,430.00 crore. The bank's net interest margin (NIM) is anticipated to contract to 2.85% from 3.15% in the previous quarter.
Tata Motors: Tata Motors is set to release its Q1 FY26 financial results today. A board of directors meeting is scheduled to approve the audited standalone and unaudited consolidated results for the quarter ended June 30, 2025. The company will also host an earnings call to discuss its financial performance with analysts and investors.
Voltas: A board meeting of Voltas Ltd is scheduled today to consider and approve the unaudited financial results for the quarter ended June 30, 2025. The trading window for the company's equity shares has been closed since June 24, 2025, and will open 48 hours after the financial results are declared.
Kalyan Jewellers: Jewellery retailer Kalyan Jewellers reported a 48.6% YoY increase in net profit, amounting to ₹264 crore. Revenue also saw a sharp rise of 31.5% to ₹7,268 crore. The company's consolidated profit after tax jumped by 48.7% compared to the same period last year, reaching ₹2,640.84 million.
Biocon: Biocon's Q1 results saw a 95% year-on-year decline in net profit. However, operating revenue increased by 15%. Revenue grew 15% to Rs 3,942 crore, fueled by Biocon Biologics' 18% growth and Syngene's 11% increase.
Global and Domestic Market Cues:
